Author Bio
I like things that go boom. Sonic or otherwise, that means I tend to gravitate towards defense and aerospace stocks. But to tell the truth, over the course of a dozen years writing for The Motley Fool, I have covered and continue to cover everything from retailers to consumer goods stocks, and from tech to banks to insurers as well. Follow me on Twitter or Facebook for the most important developments in defense & aerospace news, and other great stories besides.
What happened
Yesterday was a pretty good day for investors in unproven special purpose acquisition company (SPAC) stocks, which are designed to acquire actual operating companies, then bring them public via reverse-merger IPO. But today is a bit different.
88 Biggest Movers From Yesterday Benzinga 12/24/2020
Gainers
Ocugen, Inc. (NASDAQ: OCGN) shares climbed 222.9% to close at $2.60 on Wednesday after the company announced it will convene its Meeting of Stockholders on Dec. 23 to modify a proposal, decreasing the proposed aggregate number of shares of common stock that the Company would be authorized to issue. Ocugen shares jumped around 174% on Tuesday after the company and Bharat Biotech announced plans to co-develop a whole-virion inactivated COVID-19 vaccine candidate.
Jaguar Health, Inc. (NASDAQ: JAGX) jumped 170.3% to close at $1.07 after the company signed an agreement with a secured lender involving the $6 million sale of royalty interest in Mytesi royalties.
Author Bio
Brian Feroldi has been covering the healthcare and technology industries for The Motley Fool since 2015. Brian s investing strategy is to buy high-quality companies and then let compounding work its magic.
See all of his articles here.Follow @brianferoldi
In this episode of
Industry Focus: Wildcard, Emily Flippen and Motley Fool contributor Brian Feroldi do a deep dive into Butterfly and talk about how the company is revolutionizing the medical imaging space. Butterfly is the latest addition to companies going public via a SPAC. They get into the range and scope of the technology and its future applications and also some things to keep an eye on. They also discuss the company s financials, competitive advantages, and much more.